The Claim

In high-risk patients with atherosclerosis or diabetes and LDL-C levels of at least 90 mg/dL who have not had a prior myocardial infarction or stroke, treatment with evolocumab 140 mg administered every 2 weeks reduces the risk of a composite cardiovascular endpoint—including death from coronary heart disease, myocardial infarction, ischemic stroke, or ischemia-driven revascularization—by 19% over a period of 4.6 years compared to placebo, with a 5-year event rate of 13.4% in the evolocumab group versus 16.2% in the placebo group.

Source: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
90score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

For people at high risk for heart problems because of diabetes or clogged arteries, taking a drug called evolocumab every two weeks can lower their chances of having a heart attack, stroke, or needing heart surgery by about 1 in 5 over nearly 5 years, compared to those who don’t take it.

See the scientific wording

In high-risk patients with atherosclerosis or diabetes and LDL-C ≥90 mg/dL who have not experienced a prior myocardial infarction or stroke, evolocumab 140 mg every 2 weeks reduces the risk of a broader composite endpoint including death from coronary heart disease, myocardial infarction, ischemic stroke, or ischemia-driven revascularization by 19% over 4.6 years compared to placebo, with a 5-year event rate of 13.4% versus 16.2%

What the research says

1 study

  1. Study: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.

    The study tested the exact same drug, dose, and type of patients as in the claim, and found it reduced heart problems by 19%, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.